ESD – Lumendi

Louis Gutierrez, Clinical & Regional Sales Manager attends the Cedar-Sinai International Symposium

Lumendi shines at TxIEG 2025, a record-breaking year for the company with unprecedented interest in the DiLumen Endoluminal Interventional Platform.

LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET

“This certification is a key milestone in our global strategy to expand access to minimally invasive endoluminal procedures,” stated Peter Johann, Ph.D., Executive Chairman of Lumendi AG.

A Randomized Prospective Study Evaluating Effectiveness Of A Double Balloon Endolumenal Platform For Colorectal EndoscopicSubmucosal Dissection

Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.

Lumendi Announces CMS HCPCS Code for Reimbursement of ESD Procedures Performed in Hospital Outpatient Facilities

October 19, 2021 08:00 AM Eastern Daylight Time WESTPORT, Conn.--(BUSINESS WIRE)--Lumendi-- Effective October 1, 2021, the Centers for Medicare & Medicaid Services (CMS) established C9779 as a new Healthcare… Continue reading